Serum metabolite profiling of ST‐segment elevation myocardial infarction using liquid chromatography quadrupole time‐of‐flight mass spectrometry
- 2 November 2019
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 34 (2) , e4738
Abstract
ST segment elevation myocardial infarction (STEMI) is one of the most common global causes of cardiovascular disease‐related death. Several metabolites may change during STEMI. Hence, analysis of metabolites in body fluid may be considered as a rapid and accurate test for initial diagnosis. This study has therefore attempted to determine the variation in metabolites identified in the serum of STEMI patients (n = 20) and 15 controls. Samples collected from the Cardiology Department, Medical Faculty, Ataturk University, were extracted by liquid–liquid extraction and analysed using liquid chromatography quadrupole time‐of‐flight mass spectrometry. The METLIN database was used for the identification and characterization of metabolites. According to Q‐TOF/MS measurements, 231 m/z values, which were significantly different between groups (P < 0.01 and fold analysis >1.5) were detected. Metabolite identification was achieved via the Human Metabolome database. According to the multivariate data analysis, leucine, isoleucine, l‐proline, l‐alanine, glycine, fumaric acid, citrate, succinate and carnitine levels were decreased, whereas levels of propionic acid, maleic acid, butyric acid, urea, oleic acid, palmitic acid, lysoPC [18:2(9Z)], glycerol, phoshpatidylethanolamine, caffeine and l‐lactic acid were increased in STEMI patients compared with controls. In conclusion, malonic acid, maleic acid, fumaric acid and palmitic acid can be used as biomarkers for early risk stratification of patients with STEMI.Keywords
This publication has 31 references indexed in Scilit:
- Medical management of acute coronary syndromesJournal of the American Association of Nurse Practitioners, 2017
- Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathwayNeuropharmacology, 2016
- Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approachMolecular BioSystems, 2014
- A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancerCancer Letters, 2014
- Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndromeMetabolomics, 2013
- Targeting fatty acid and carbohydrate oxidation — A novel therapeutic intervention in the ischemic and failing heartBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Troponin elevation in coronary vs. non-coronary diseaseEuropean Heart Journal, 2010
- Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease—KOZANI STUDYTranslational Research, 2010
- Pharmacokinetics of L-CarnitineClinical Pharmacokinetics, 2003
- Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular DiseaseDiabetes Care, 1991